Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery

被引:4
|
作者
Singh, Vijai [1 ]
Somvanshi, Pallavi [1 ]
机构
[1] Bioinformat Ctr, Lucknow, Uttar Pradesh, India
关键词
Mycobacterium tuberculosis; Peptide deformylase; Docking; Phylogeny; Drugs;
D O I
10.2174/157018009789108286
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Peptide deformylase (PDF) is a ubiquitous bacterial metalloenzyme responsible to cleave the formyl group from nascent polypeptides, supporting in the maturation. It plays a vital role in the survival of bacterial cells which is conserved in the eubacteria and is considered to be an attractive target for developing new antibacterial agents. Homology modeling was employed for generation of 3-D structure of PDF of M. tuberculosis H37Rv and showed 92.5% amino acid in the allowed region of Ramachandran plot. PDF was used as target for a set of inhibitors with substantial structural differences. Docking results show that the BB-3497, BBS-54, Actinonin and BBS-02 bind with high affinity to enzyme active site. Phylogeny of PDF in M. tuberculosis H37Rv shows homology with other strains of pathogenic bacteria. These data validate PDF as a novel target for the design of a new generation of antimycobacterial agents.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 50 条
  • [41] Evaluation of Therapeutic Effect and Nursing Significance of novel Peptide Targeting Mycobacterium tuberculosis on Laryngeal Tuberculosis
    Shi, Yan
    Lu, Qiaoqin
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (04): : 801 - 804
  • [42] The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery
    Brennan, Patrick J.
    Crick, Dean C.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (05) : 475 - 488
  • [43] A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
    Laurent R. Chiarelli
    Giorgia Mori
    Beatrice Silvia Orena
    Marta Esposito
    Thomas Lane
    Ana Luisa de Jesus Lopes Ribeiro
    Giulia Degiacomi
    Júlia Zemanová
    Sára Szádocka
    Stanislav Huszár
    Zuzana Palčeková
    Marcello Manfredi
    Fabio Gosetti
    Joël Lelièvre
    Lluis Ballell
    Elena Kazakova
    Vadim Makarov
    Emilio Marengo
    Katarina Mikusova
    Stewart T. Cole
    Giovanna Riccardi
    Sean Ekins
    Maria Rosalia Pasca
    Scientific Reports, 8
  • [44] Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery
    Lane, Thomas
    Russo, Daniel P.
    Zorn, Kimberley M.
    Clark, Alex M.
    Korotcov, Alexandru
    Tkachenko, Valery
    Reynolds, Robert C.
    Perryman, Alexander L.
    Freundlich, Joel S.
    Ekins, Sean
    MOLECULAR PHARMACEUTICS, 2018, 15 (10) : 4346 - 4360
  • [45] Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection
    Quan, Yuan
    Xiong, Le
    Chen, Jing
    Zhang, Hong-Yu
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2017, 35 (03): : 616 - 621
  • [46] A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
    Chiarelli, Laurent R.
    Mori, Giorgia
    Orena, Beatrice Silvia
    Esposito, Marta
    Lane, Thomas
    de Jesus Lopes Ribeiro, Ana Luisa
    Degiacomi, Giulia
    Zemanova, Julia
    Szadocka, Sara
    Huszar, Stanislav
    Palcekova, Zuzana
    Manfredi, Marcello
    Gosetti, Fabio
    Lelievre, Joel
    Ballell, Lluis
    Kazakova, Elena
    Makarov, Vadim
    Marengo, Emilio
    Mikusova, Katarina
    Cole, Stewart T.
    Riccardi, Giovanna
    Ekins, Sean
    Pasca, Maria Rosalia
    SCIENTIFIC REPORTS, 2018, 8
  • [47] Comparing and validating machine learning models for Mycobacterium tuberculosis drug discovery
    Lane, Thomas
    Russo, Daniel
    Zorn, Kimberley
    Clark, Alex
    Korotcov, Alexandru
    Tkachenko, Valery
    Reynolds, Robert
    Perryman, Alexander
    Freundlich, Joel
    Ekins, Sean
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [48] Hybridization Approach to Drug Discovery Inhibiting Mycobacterium tuberculosis-An Overview
    Zampieri, Daniele
    Mamolo, Maria G.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2021, 21 (09) : 777 - 788
  • [49] In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection
    Parish, Tanya
    EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (03) : 349 - 358
  • [50] Discovery of potent antimycobacterial agents targeting lumazine synthase (RibH) of Mycobacterium tuberculosis
    Singh, Monica
    Dhanwal, Anannya
    Verma, Arpita
    Augustin, Linus
    Kumari, Niti
    Chakraborti, Soumyananda
    Agarwal, Nisheeth
    Sriram, Dharmarajan
    Dey, Ruchi Jain
    SCIENTIFIC REPORTS, 2024, 14 (01):